Go Pro

Yield10 Bioscience (YTEN) Competitors

Yield10 Bioscience logo

YTEN vs. EDBL, ORIS, SANW, SISI, and AAGRW

Should you buy Yield10 Bioscience stock or one of its competitors? MarketBeat compares Yield10 Bioscience with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Yield10 Bioscience include Edible Garden (EDBL), Oriental Rise (ORIS), S&W Seed (SANW), Shineco (SISI), and African Agriculture (AAGRW). These companies are all part of the "agriculture" industry.

How does Yield10 Bioscience compare to Edible Garden?

Yield10 Bioscience (NASDAQ:YTEN) and Edible Garden (NASDAQ:EDBL) are both small-cap consumer staples companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, media sentiment, analyst recommendations and profitability.

In the previous week, Edible Garden had 3 more articles in the media than Yield10 Bioscience. MarketBeat recorded 3 mentions for Edible Garden and 0 mentions for Yield10 Bioscience. Edible Garden's average media sentiment score of 0.67 beat Yield10 Bioscience's score of 0.00 indicating that Edible Garden is being referred to more favorably in the news media.

Company Overall Sentiment
Yield10 Bioscience Neutral
Edible Garden Positive

4.9% of Yield10 Bioscience shares are held by institutional investors. Comparatively, 13.0% of Edible Garden shares are held by institutional investors. 6.1% of Yield10 Bioscience shares are held by insiders. Comparatively, 0.8% of Edible Garden shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Yield10 Bioscience has a beta of 1.48, indicating that its share price is 48% more volatile than the broader market. Comparatively, Edible Garden has a beta of 1.7, indicating that its share price is 70% more volatile than the broader market.

Yield10 Bioscience has higher earnings, but lower revenue than Edible Garden. Edible Garden is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A
Edible Garden$12.81M0.05-$17.33M-$109.66N/A

Edible Garden has a consensus price target of $1.00, suggesting a potential upside of 693.65%. Given Edible Garden's stronger consensus rating and higher probable upside, analysts plainly believe Edible Garden is more favorable than Yield10 Bioscience.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Edible Garden
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Yield10 Bioscience has a net margin of 0.00% compared to Edible Garden's net margin of -131.59%.

Company Net Margins Return on Equity Return on Assets
Yield10 BioscienceN/A N/A -296.08%
Edible Garden -131.59%N/A -88.36%

Summary

Edible Garden beats Yield10 Bioscience on 9 of the 14 factors compared between the two stocks.

How does Yield10 Bioscience compare to Oriental Rise?

Yield10 Bioscience (NASDAQ:YTEN) and Oriental Rise (NASDAQ:ORIS) are both small-cap consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership, analyst recommendations and media sentiment.

4.9% of Yield10 Bioscience shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Oriental Rise had 1 more articles in the media than Yield10 Bioscience. MarketBeat recorded 1 mentions for Oriental Rise and 0 mentions for Yield10 Bioscience. Yield10 Bioscience's average media sentiment score of 0.00 equaled Oriental Rise'saverage media sentiment score.

Company Overall Sentiment
Yield10 Bioscience Neutral
Oriental Rise Neutral

Yield10 Bioscience has a beta of 1.48, suggesting that its stock price is 48% more volatile than the broader market. Comparatively, Oriental Rise has a beta of 1.54, suggesting that its stock price is 54% more volatile than the broader market.

Given Yield10 Bioscience's higher probable upside, equities research analysts plainly believe Yield10 Bioscience is more favorable than Oriental Rise.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Oriental Rise
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Oriental Rise has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A
Oriental Rise$12.22M0.04$680KN/AN/A

Company Net Margins Return on Equity Return on Assets
Yield10 BioscienceN/A N/A -296.08%
Oriental Rise N/A N/A N/A

Summary

Oriental Rise beats Yield10 Bioscience on 6 of the 9 factors compared between the two stocks.

How does Yield10 Bioscience compare to S&W Seed?

S&W Seed (NASDAQ:SANW) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, risk, analyst recommendations, dividends, media sentiment, institutional ownership and profitability.

S&W Seed has a beta of -1.11, meaning that its share price is 211% less volatile than the broader market. Comparatively, Yield10 Bioscience has a beta of 1.48, meaning that its share price is 48% more volatile than the broader market.

61.7% of S&W Seed shares are owned by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are owned by institutional investors. 11.4% of S&W Seed shares are owned by company insiders. Comparatively, 6.1% of Yield10 Bioscience shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Yield10 Bioscience has a net margin of 0.00% compared to S&W Seed's net margin of -85.38%. Yield10 Bioscience's return on equity of 0.00% beat S&W Seed's return on equity.

Company Net Margins Return on Equity Return on Assets
S&W Seed-85.38% -50.81% -17.71%
Yield10 Bioscience N/A N/A -296.08%

In the previous week, S&W Seed's average media sentiment score of 0.00 equaled Yield10 Bioscience'saverage media sentiment score.

Company Overall Sentiment
S&W Seed Neutral
Yield10 Bioscience Neutral

Yield10 Bioscience has lower revenue, but higher earnings than S&W Seed. S&W Seed is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
S&W Seed$54.99M0.00-$30.03M-$7.72N/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

Summary

S&W Seed beats Yield10 Bioscience on 6 of the 10 factors compared between the two stocks.

How does Yield10 Bioscience compare to Shineco?

Shineco (NASDAQ:SISI) and Yield10 Bioscience (NASDAQ:YTEN) are both small-cap agriculture companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

Shineco has a beta of -1.89, indicating that its stock price is 289% less volatile than the broader market. Comparatively, Yield10 Bioscience has a beta of 1.48, indicating that its stock price is 48% more volatile than the broader market.

Given Yield10 Bioscience's higher possible upside, analysts plainly believe Yield10 Bioscience is more favorable than Shineco.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shineco
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Yield10 Bioscience
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Yield10 Bioscience has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Yield10 Bioscience's return on equity of 0.00% beat Shineco's return on equity.

Company Net Margins Return on Equity Return on Assets
Shineco-380.55% -79.89% -33.01%
Yield10 Bioscience N/A N/A -296.08%

4.1% of Shineco shares are held by institutional investors. Comparatively, 4.9% of Yield10 Bioscience shares are held by institutional investors. 0.0% of Shineco shares are held by company insiders. Comparatively, 6.1% of Yield10 Bioscience shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Shineco's average media sentiment score of 0.00 equaled Yield10 Bioscience'saverage media sentiment score.

Company Overall Sentiment
Shineco Neutral
Yield10 Bioscience Neutral

Yield10 Bioscience has lower revenue, but higher earnings than Shineco. Shineco is trading at a lower price-to-earnings ratio than Yield10 Bioscience, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shineco$9.60M0.00-$22.45M-$204.00N/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

Summary

Yield10 Bioscience beats Shineco on 8 of the 12 factors compared between the two stocks.

How does Yield10 Bioscience compare to African Agriculture?

African Agriculture (NASDAQ:AAGRW) and Yield10 Bioscience (NASDAQ:YTEN) are both agriculture companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

4.9% of Yield10 Bioscience shares are owned by institutional investors. 6.1% of Yield10 Bioscience shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

African Agriculture has higher revenue and earnings than Yield10 Bioscience.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
African Agriculture$1.75MN/AN/AN/AN/A
Yield10 Bioscience$60K0.00-$14.45M-$26.12N/A

Company Net Margins Return on Equity Return on Assets
African AgricultureN/A N/A N/A
Yield10 Bioscience N/A N/A -296.08%

In the previous week, African Agriculture had 4 more articles in the media than Yield10 Bioscience. MarketBeat recorded 4 mentions for African Agriculture and 0 mentions for Yield10 Bioscience. Yield10 Bioscience's average media sentiment score of 0.00 beat African Agriculture's score of -0.11 indicating that Yield10 Bioscience is being referred to more favorably in the news media.

Company Overall Sentiment
African Agriculture Neutral
Yield10 Bioscience Neutral

Summary

African Agriculture and Yield10 Bioscience tied by winning 3 of the 6 factors compared between the two stocks.

Get Yield10 Bioscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for YTEN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding YTEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

YTEN vs. The Competition

MetricYield10 BioscienceAgricultural production IndustryStaples SectorNASDAQ Exchange
Market Cap$257K$65.42M$16.76B$12.48B
Dividend YieldN/AN/A3.29%6.52%
P/E Ratio0.00N/A26.9524.70
Price / SalesN/A0.3547.2599.49
Price / CashN/AN/A16.8757.09
Price / BookN/A0.495.666.46
Net Income-$14.45M-$186.49M$680.96M$337.01M

Yield10 Bioscience Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
YTEN
Yield10 Bioscience
N/AN/AN/AN/A$257K$60KN/A30
EDBL
Edible Garden
3.5914 of 5 stars
$0.17
-12.1%
$1.00
+498.8%
-99.5%$913K$12.81MN/A50
ORIS
Oriental Rise
0.5018 of 5 stars
$1.83
flat
N/AN/A$512K$12.22MN/AN/A
SANW
S&W Seed
N/A$0.04
flat
N/AN/A$80K$54.99MN/A180
SISI
Shineco
N/A$0.00
flat
N/A-100.0%$1K$9.60MN/A70

Related Companies and Tools


This page (NASDAQ:YTEN) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners